1. Wulczyn, E., et al.: Predicting prostate cancer specific mortality with artificial intelligence-based Gleason Grading. Commun. Med. 1(10). https://doi.org/10.1038/s43856021-00005-3
2. https://ourworldindata.org/cancer
3. Jemal, A., Ward, E.M., Johnson, C.J., Cronin, K.A., Ma, J., Ryerson, A.B., Mariotto, A., Lake, A.J., Wilson, R., Sherman, R.L., Anderson, R.N., Hensley, S.J., Kohler, B.A., Penberthy, L., Feuer, E.J., Weir, H.K.: Annual report to the nation of the status of cancer, 1975–2014, feature survival, JNCI: J. Natl. Cancer Inst. 109, 9 (2017). https://doi.org/10.1093/jnci/djx030
4. Allemani, C., Weirm H.K., Carreira, H., Harewood, R., Spika, D., Wang, X.S., Bannon, F., Ahn, J.V., Johnson, C.J., Bonaventure, A., Gragera, R.M., Stiller, C., Azevedo e Silva, G., Chen, W.Q., Ogunbiyi, O., Rachet, B., Soeberg, M., You, H., Coleman, M.P.: Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385(9972), 977–1010 (2015)
5. WHO (2012). Decisions and list of resolutions of the 65th World Health Assembly: prevention and control of noncommunicable diseases: follow-up to the high-level meeting of the United Nations General Assembly on the prevention and control of non-communicable diseases (A65/DIV/3). World Health Organization, Geneva